These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10720065)

  • 1. Close correlation between estrogen treatment and renal phosphate reabsorption capacity.
    Uemura H; Irahara M; Yoneda N; Yasui T; Genjida K; Miyamoto KI; Aono T; Takeda E
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1215-9. PubMed ID: 10720065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of parathyroid hormone and 1,25-dihydroxyvitamin D3 on tubular handling of phosphate in hypophosphatemic rickets.
    Alon U; Chan JC
    J Clin Endocrinol Metab; 1984 Apr; 58(4):671-5. PubMed ID: 6546575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal handling of phosphate in relation to serum parathyroid hormone levels.
    Madsen S; Olgaard K; Ladefoged J
    Acta Med Scand; 1976; 200(1-2):7-10. PubMed ID: 785962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormalities in renal tubular phosphate handling in children with sickle cell disease.
    Raj VM; Freundlich M; Hamideh D; Alvarez O; Seeherunvong W; Abitbol C; Katsoufis C; Chandar J; Ruiz P; Zilleruelo G
    Pediatr Blood Cancer; 2014 Dec; 61(12):2267-70. PubMed ID: 25132581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Has vitamin D a direct renal effect on the tubular reabsorption of phosphate? A study in parathyroidectomized (PTX) and non-PTX man.
    Madsen S; Olgaard K
    Adv Exp Med Biol; 1978; 103():111-23. PubMed ID: 717102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The maximal tubular reabsorption of phosphate in relation to serum parathyroid hormone.
    Madsen S; Olgaard K; Ladefoged J
    Adv Exp Med Biol; 1977; 81():141-8. PubMed ID: 899923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating osteoprotegerin in women during GnRH-agonist treatment and their relationships with mineral components and biomarkers of bone turnover.
    Uemura H; Yasui T; Umino Y; Niki H; Takikawa M; Saito S; Furumoto H; Irahara M
    Bone; 2003 Nov; 33(5):860-6. PubMed ID: 14623063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Conservative surgery combined with depot medroxyprogesterone acetate in treatment of moderate or severe endometriosis].
    Zhou J; Lei ZW; Lü JQ; Sun J; Xu XW
    Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):5-8. PubMed ID: 15774083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum estradiol concentration as measured by HPLC-RIA and bone mineral density in postmenopausal women during hormone replacement therapy.
    Yasui T; Uemura H; Umino Y; Takikawa M; Kuwahara A; Saito S; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
    Horm Res; 2004; 61(3):117-25. PubMed ID: 14676459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-Alpha-hydroxycholecalciferol-induced changes in the renal heandling of phosphate and the serum parathyroid hormone level.
    Madsen S; Olgaard K; Ladefoged J
    Acta Med Scand; 1976; 200(5):351-4. PubMed ID: 983805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin-releasing hormone analogue plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trial.
    Gregoriou O; Konidaris S; Vitoratos N; Papadias C; Papoulias I; Chryssicopoulos A
    Int J Fertil Womens Med; 1997; 42(6):406-11. PubMed ID: 9459084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating parathyroid hormone activity: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism.
    Marx SJ; Spiegel AM; Brown EM; Windeck R; Gardner DG; Downs RW; Attie M; Aurbach GD
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1190-7. PubMed ID: 233692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Handling of phosphate by the transplanted kidney.
    Graf H; Kovarik J; Stummvoll HK; Wolf A; Pinggera WF
    Proc Eur Dial Transplant Assoc; 1979; 16():624-9. PubMed ID: 398523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphate metabolism in renal stone formers. (II): Relation to renal tubular functions and calcium metabolism.
    Wikström B; Backman U; Danielson BG; Fellström B; Johansson G; Ljunghall S; Wide L
    Scand J Urol Nephrol Suppl; 1981; 61():II:1-26. PubMed ID: 6274002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis.
    Regidor PA; Regidor M; Schmidt M; Ruwe B; Lübben G; Förtig P; Kienle E; Schindler AE
    Gynecol Endocrinol; 2001 Jun; 15(3):202-9. PubMed ID: 11447732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency.
    Finkelstein JS; Klibanski A; Schaefer EH; Hornstein MD; Schiff I; Neer RM
    N Engl J Med; 1994 Dec; 331(24):1618-23. PubMed ID: 7969342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of every-other-day administration of conjugated equine estrogen and medroxyprogesterone acetate on gonadotropin-releasing hormone agonists treatment in women with endometriosis.
    Irahara M; Uemura H; Yasui T; Kinoshita H; Yamada M; Tezuka M; Kiyokawa M; Kamada M; Aono T
    Gynecol Obstet Invest; 2001; 52(4):217-22. PubMed ID: 11729332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of renal calcium conservation with estrogen replacement therapy in women in early postmenopause--a clinical research center study.
    McKane WR; Khosla S; Burritt MF; Kao PC; Wilson DM; Ory SJ; Riggs BL
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3458-64. PubMed ID: 8530583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation.
    Tomida K; Hamano T; Ichimaru N; Fujii N; Matsui I; Nonomura N; Tsubakihara Y; Rakugi H; Takahara S; Isaka Y
    Bone; 2012 Oct; 51(4):729-36. PubMed ID: 22796419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.